Document Type: RESEARCH PAPER

Authors

The Rothman Institute at Thomas Jefferson University, Philadelphia, PA, USA

Abstract

Background: Allogeneic blood transfusion in patients undergoing total joint arthroplasty (TJA) has been shown to
negatively affect patient outcomes. This study aimed to examine if there is a correlation between operative time and the
need for allogeneic blood transfusions during TJA.
Methods: We performed a retrospective review of 866 patients who underwent primary TJA during a one-year period
at our institution. Logistic regression was performed to identify the association between operative time and need for
allogeneic blood transfusion, controlling for other patient and surgical factors. Multiple linear regression analysis was
also performed to see how the same factors affected CBL.
Results: Of the 866 cases, 13%(115) were simultaneous bilateral. 52%(449) of patients received preoperative
autologous blood donation. The average operative time for unilateral and bilateral patients was 74.1±(33.9) and
132.6±(36.0) minutes, respectively. Average CBL for unilateral patients was 2120mL±(1208) and 4051mL±(1311) for
bilateral cases. The average number of allogeneic transfusions was also higher within the bilateral group (0.49 vs 1.15
units). Multivariate analysis indicated that duration of surgery (odds ratio [OR]:1.35 per 15 minutes) and bilateral TJA
(OR: 2.97) increase the risk of allogeneic blood transfusion, while patients having total knee arthroplasty are less likely
to receive allogeneic blood transfusion (OR: 0.50). CBL also increased significantly with surgical duration (211.5 mL
per 15 minutes).
Conclusion: A subgroup analysis confirmed that there was a correlation between operative time and need for
allogeneic transfusion following unilateral TJA. Expeditious surgery can minimize blood loss and subsequent need for
blood transfusion and its associated adverse consequences.

Keywords

Main Subjects

1. Cram P, Lu X, Kaboli PJ, Vaughan-Sarrazin MS, Cai X,
Wolf BR, et al. Clinical characteristics and outcomes of
Medicare patients undergoing total hip arthroplasty.
1991-2008. JAMA. 2011; 305(15):1560-7.
2. Cram P, Lu X, Kates SL, Singh JA, Li Y, Wolf BR. Total
knee arthroplasty volume, utilization, and outcomes
among Medicare beneficiaries, 1991-2010. JAMA.
2012; 308(12):1227-36.
3. Parvizi J, Chaudhry S, Rasouli MR, Pulido L, Joshi
A, Herman JH, et al. Who needs autologous blood
donation in joint replacement? J Knee Surg. 2011;
24(1):25-31.
4. Spahn DR. Anemia and patient blood management
in hip and knee surgery: a systematic review of the
literature. Anesthesiology. 2010; 113(2):482-95.
5. Martinez V, Monsaingeon-Lion A, Cherif K, Judet
T, Chauvin M, Fletcher D. Transfusion strategy for
primary knee and hip arthroplasty: impact of an
algorithm to lower transfusion rates and hospital
costs. Br J Anaesth. 2007; 99(6):794-800.
6. Thomassen BJ, Pilot P, Scholtes VA, Grohs JG, Holen
K, Bisbe E, et al. Limit allogeneic blood use with
routine re-use of patient’s own blood: a prospective,
randomized, controlled trial in total hip surgery. PLoS
One. 2012; 7(9):e44503.
7. Innerhofer P, Klingler A, Klimmer C, Fries D,
Nussbaumer W. Risk for postoperative infection after
transfusion of white blood cell-filtered allogeneic or
autologous blood components in orthopedic patients
undergoing primary arthroplasty. Transfusion. 2005;
45(1):103-10.
8. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE,
Tooms RE, Welch RB. An analysis of blood management
in patients having a total hip or knee arthroplasty. J
Bone Joint Surg Am. 1999; 81(1):2-10.
9. Pedersen AB, Mehnert F, Overgaard S, Johnsen SP.
Allogeneic blood transfusion and prognosis following
total hip replacement: a population-based follow up
study. BMC Musculoskelet Disord. 2009; 10(1):167.
10. Borghi B, Casati A. Incidence and risk factors for
allogeneic blood transfusion during major joint
replacement using an integrated autotransfusion
regimen. Eur J Anaesthesiol. 2000; 17(7):411-7.
11. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J.
Periprosthetic joint infection: the incidence, timing,
and predisposing factors. Clin Orthop Relat Res. 2008;
466(7):1710-5.
12. Noticewala MS, Nyce JD, Wang W, Geller JA, Macaulay
W. Predicting need for allogeneic transfusion
after total knee arthroplasty. J Arthroplasty. 2012;
27(6):961-7.
13. Rosencher N, Kerkkamp HE, Macheras G, Munuera
LM, Menichella G, Barton DM, et al. Orthopedic
Surgery Transfusion Hemoglobin European Overview
(OSTHEO) study: blood management in elective knee
and hip arthroplasty in Europe. Transfusion. 2003;
43(4):459-69.

14. Feagan BG, Wong CJ, Lau CY, Wheeler SL, Sue-AQuan
G, Kirkley A. Transfusion practice in elective
orthopedic surgery. Transfus Med. 2001; 11(2):87-95.
15. Callaghan JJ, O’Rourke MR, Liu SS. Blood management:
issues and options. J Arthroplasty. 2005; 20(4 suppl
2):51-4.
16. Liu X, Zhang X, Chen Y, Wang Q, Jiang Y, Zeng B. Hidden
blood loss after total hip arthroplasty. J Arthroplasty.
2011; 26(7):1100-5.
17. Karimi M, Florentino-Pineda I, Weatherred T, Qadeer
A, Rosenberg CA, Hudacko A, et al. Blood conservation
operations in pediatric cardiac patients: a paradigm
shift of blood use. Ann Thorac Surg. 2013; 95(3):962-7.
18. Weber EW, Slappendel R, Prins MH, van der Schaaf
DB, Durieux ME, Strümper D. Perioperative blood
transfusions and delayed wound healing after
hip replacement surgery: effects on duration of
hospitalization. Anesth Analg. 2005; 100(5):1416-21.
19. Vamvakas EC, Blajchman MA. Transfusion-related
immunomodulation (TRIM): an update.
Blood Rev.
2007; 21(6):327-48.
20. Yomtovian R, Kruskall MS, Barber JP. Autologous blood
transfusion: the reimbursement dilemma. J Bone Joint
Surg Am. 1992; 74(8):1265-72.
21. Spahn DR, Casutt M. Eliminating blood transfusions:
new aspects and perspectives. Anesthesiology. 2000;
93(1):242-55.
22. Kleinert K, Theusinger OM, Nuernberg J, Werner CM.
Alternative procedures for reducing allogeneic blood
transfusion in elective orthopedic surgery. HSS J.
2010; 6(2):190-8.
23. Bong MR, Patel V, Chang E, Issack PS, Hebert R, Di
Cesare PE. Risks associated with blood transfusion
after total knee arthroplasty. J Arthroplasty. 2004;
19(3):281-7.
24. Grosflam JM, Wright EA, Cleary PD, Katz JN. Predictors
of blood loss during total hip replacement surgery.
Arthritis Care Res. 1995; 8(3):167-73.
25. Sharrock NE, Mineo R, Urquhart B, Salvati EA. The
effect of two levels of hypotension on intraoperative
blood loss during total hip arthroplasty performed
under lumbar epidural anesthesia. Anesth Analg.
1993; 76(3):580-4.
26. An HS, Mikhail WE, Jackson WT, Tolin B, Dodd GA.
Effects of hypotensive anesthesia, nonsteroidal
antiinflammatory drugs, and polymethylmethacrylate
on bleeding in total hip arthroplasty patients. J
Arthroplasty. 1991; 6(3):245-50.
27. Bowditch MG, Villar RN. Do obese patients bleed
more? A prospective study of blood loss at total hip
replacement. Ann R Coll Surg Engl. 1999; 81(3):198-
200.
28. Pola E, Papaleo P, Santoliquido A, Gasparini G, Aulisa
L, De Santis E. Clinical factors associated with an
increased risk of perioperative blood transfusion in
nonanemic patients undergoing total hip arthroplasty.
J Bone Joint Surg Am. 2004; 86-A(1):57-61.

29. Pagnano M, Cushner FD, Hansen A, Scuderi GR, Scott
WN. Blood management in two-stage revision knee
arthroplasty for deep prosthetic infection. Clin Orthop
Relat Res. 1999; 367(1):238-42.
30. Zheng F, Cammisa FP Jr, Sandhu HS, Girardi FP, Khan
SN. Factors predicting hospital stay, operative time,
blood loss, and transfusion in patients undergoing
revision posterior lumbar spine decompression,
fusion, and segmental instrumentation. Spine (Phila
Pa 1976). 2002; 27(8):818-24.
31. Prasad N, Padmanabhan V, Mullaji A. Blood loss in
total knee arthroplasty: an analysis of risk factors. Int
Orthop. 2007; 31(1):39-44.
32. Kolisek FR, Bonutti PM, Hozack WJ, Purtill J, Sharkey
PF, Zelicof SB, et al. Clinical experience using a
minimally invasive surgical approach for total
knee arthroplasty: early results of a prospective
randomized study compared to a standard approach.
J Arthroplasty. 2007; 22(1):8-13.
33. Parvizi J, Pour AE, Peak EL, Sharkey PF, Hozack WJ,
Rothman RH. One-stage bilateral total hip arthroplasty
compared with unilateral total hip arthroplasty: a
prospective study. J Arthroplasty. 2006; 21(6 Suppl
2):S26-31.
34. Cushner FD, Friedman RJ. Blood loss in total knee
arthroplasty. Clin Orthop Relat Res. 1991; 269(1):98-
101.
35. Brodsky JW, Dickson JH, Erwin WD, Rossi CD.
Hypotensive anesthesia for scoliosis surgery in
Jehovah’s Witnesses. Spine. 1991; 16(3):304-6.
36. Fosco M, Di Fiore M. Factors predicting blood
transfusion in different surgical procedures for
degenerative spine disease. Eur Rev Med Pharmacol
Sci. 2012; 16(13):1853-8.
37. Kawai A, Kadota H, Yamaguchi U, Morimoto Y, Ozaki T,
Beppu Y. Blood loss and transfusion associated with
musculoskeletal tumor surgery. J Surg Oncol. 2005;
92(1):52-8.